Rankings · Stocks
Best-performing Stocks
Compare investable companies across valuation, growth, quality, income and returns.
Latest complete snapshotNov 1, 2026
What the data shows
Mega Fortune Company Limited Ordinary Shares (MGRT) is first on the displayed page, with +2315.48% 1y in USD. Returns in different listing currencies are not directly comparable.
Displayed results · Prices through Oct 30, 2026
Stock returns use each listing’s quoted currency. A combined distribution is omitted where currencies differ.
Top 10 · Full-universe context
1Y total return
Select a measure to rank the qualifying universe. The area locates the full ranked set.
1
MGRTMega Fortune Company Limited Ordinary Shares+2315.48%
+2315.48%
2
NLSTNetlist Inc+887.50%
+887.50%
3
MRNAModerna Inc+716.35%
+716.35%
4
AXTIAXT Inc+592.58%
+592.58%
5
ERASErasca Inc+492.98%
+492.98%
6
CDNACareDx Inc+482.73%
+482.73%
7
SNDKSandisk Corp+477.38%
+477.38%
8
KODKodiak Sciences Inc+447.20%
+447.20%
9
SLSSellas Life Sciences Group Inc+431.87%
+431.87%
10
TXG10X Genomics Inc+414.00%
+414.00%
A comparable full-universe distribution is unavailable for this measure. Different currencies or yield bases are not combined.
| Rank | Instrument | Classification | Region | Market cap | 1M* | YTD* | 1Y* |
|---|---|---|---|---|---|---|---|
| 1 | MGRTMega Fortune Company Limited Ordinary Shares | Stock | North America | $1.4B | +15.13% | +1479.23% | +2315.48% |
| 2 | NLSTNetlist Inc | Stock | North America | $2.3B | +11.66% | +610.11% | +887.50% |
| 3 | MRNAModerna Inc | Stock | North America | $55.1B | +16.69% | +651.85% | +716.35% |
| 4 | AXTIAXT Inc | Stock | North America | $4.4B | -35.88% | +236.76% | +592.58% |
| 5 | ERASErasca Inc | Stock | North America | $6.8B | -2.65% | +285.75% | +492.98% |
| 6 | CDNACareDx Inc | Stock | North America | $2.6B | +30.17% | +363.96% | +482.73% |
| 7 | SNDKSandisk Corp | Stock | North America | $217.4B | -33.09% | +384.83% | +477.38% |
| 8 | KODKodiak Sciences Inc | Stock | North America | $2.5B | +5.01% | +254.72% | +447.20% |
| 9 | SLSSellas Life Sciences Group Inc | Stock | North America | $2.7B | -17.55% | +156.76% | +431.87% |
| 10 | TXG10X Genomics Inc | Stock | North America | $8B | -25.02% | +329.86% | +414.00% |
Informational only. Rankings are not investment advice, a recommendation, or a prediction of future performance.